

[ Thu, Feb 27th 2020
] - WOPRAI
[ Thu, Feb 27th 2020
] - WOPRAI
[ Thu, Feb 27th 2020
] - WOPRAI
[ Thu, Feb 27th 2020
] - WOPRAI

[ Wed, Feb 26th 2020
] - WOPRAI
[ Wed, Feb 26th 2020
] - WOPRAI
[ Wed, Feb 26th 2020
] - WOPRAI
[ Wed, Feb 26th 2020
] - WOPRAI
[ Wed, Feb 26th 2020
] - WOPRAI
[ Wed, Feb 26th 2020
] - WOPRAI
[ Wed, Feb 26th 2020
] - WOPRAI
[ Wed, Feb 26th 2020
] - WOPRAI
[ Wed, Feb 26th 2020
] - WOPRAI
[ Wed, Feb 26th 2020
] - WOPRAI
[ Wed, Feb 26th 2020
] - WOPRAI
[ Wed, Feb 26th 2020
] - WOPRAI
[ Wed, Feb 26th 2020
] - WOPRAI
[ Wed, Feb 26th 2020
] - WOPRAI
[ Wed, Feb 26th 2020
] - WOPRAI
[ Wed, Feb 26th 2020
] - WOPRAI
[ Wed, Feb 26th 2020
] - WOPRAI
[ Wed, Feb 26th 2020
] - WOPRAI
David Lebovitz Maintained (ASND) at Buy with Increased Target to $181 on, Feb 26th, 2020
David Lebovitz of Morgan Stanley, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $148 to $181 on, Feb 26th, 2020.
David, nor any peers, have made any analyst calls on ASND in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources
Similar Stocks and Investing Articles
[ Tue, Feb 11th 2020
] - WOPRAI
[ Fri, Feb 07th 2020
] - WOPRAI
[ Fri, Jan 17th 2020
] - WOPRAI
[ Tue, Dec 17th 2019
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
[ Tue, Oct 22nd 2019
] - WOPRAI
[ Wed, Feb 28th 2018
] - WOPRAI
[ Tue, Feb 27th 2018
] - WOPRAI
[ Mon, Feb 26th 2018
] - WOPRAI